Bleximo — Superconducting Qubits · fobi

Bleximo

Bleximo develops superconducting quantum processors optimized for quantum simulation and chemistry applications. Bleximo raised seed funding and operates quietly. The company is a spinout from the lab of Irfan Siddiqi at UC Berkeley.

Founded by UC Berkeley quantum computing pioneers, the company focuses on specialized processors for near-term chemistry use cases.

bleximo.com Superconducting Qubits

United Statesprivate

At a glance

Total raised

$1.5M

last round seed

Headcount

11-50

approximate · public range

Headquarters

Berkeley

United States

Founded

2018

8 years active

Status

Private

Superconducting Qubits

Subsector

For subscribers

Subscribe to see the full profile

Including Funding rounds, Bull / Bear thesis, Stock + earnings, Roster changes, Patents, News, and Open roles.

Already subscribed? Sign in →

Date	Stage	Amount	Valuation	Lead investors
Sep 25, 2018	Seed	$1.5M	—	Eniac Ventures

AI bull / bear

Bull case

Bleximo plays a smart contrarian bet in superconducting qubits. While giants like IBM and Google race toward general-purpose fault-tolerant machines, Bleximo targets specialized processors for quantum simulation and chemistry — a narrower path that could yield commercial value sooner. The pedigree is real: a spinout from Irfan Siddiqi's lab at UC Berkeley, one of the most respected superconducting qubit groups in academia. That lineage gives the team deep fabrication and device physics expertise that most seed-stage competitors lack. Chemistry use cases — drug discovery, materials design, catalyst modeling — represent the most concrete near-term applications for quantum advantage. If Bleximo can build purpose-built processors that outperform classical methods on specific molecular simulations, it doesn't need thousands of logical qubits to deliver value. Specialization reduces the engineering burden and could let them ship useful hardware while general-purpose rivals remain years away from error correction thresholds.

Bear case

Bleximo faces a brutal capital and talent war with no visible ammunition. The company has undisclosed seed funding and no funding history on record, which in superconducting qubits means almost nothing. Building a fabrication line and cryogenic infrastructure requires tens to hundreds of millions of dollars. Rigetti raised over $300 million and still struggles; IonQ went public at nearly $2 billion. Bleximo operates quietly — which can signal pre-commercial limbo rather than strategic stealth. The specialized processor thesis sounds elegant but introduces a chicken-and-egg problem: chemistry customers need proven hardware before they commit, and Bleximo needs customer revenue to fund hardware iteration. Meanwhile, IBM's roadmaps, Google's Willow chip, and well-capitalized startups are all pursuing general-purpose architectures that will eventually subsume niche use cases. Without a clear funding round, major customer partnership, or published benchmark results, Bleximo risks being outspent and outperformed before its specialization thesis can even be tested.

Generated by deepseek-v4-flash · June 2, 2026Refreshes quarterly · see disclosures

Bleximo

At a glance

Subscribe to see the full profile

Funding history

How they make money

Founder backgrounds

Alexei Marchenkov

AI bull / bear

In the news

Leadership

Products

qASIC Quantum Accelerator

Cryogenic Rubicon Platform